By Finance Pulse in pharmaceuticals —

Sanofi and Maze Deal for MZE001 Terminated

Sanofi's agreement with Maze Therapeutics for the development of MZE001 was terminated following an FTC complaint. Explore the implications of this decision.

A modern, abstract illustration featuring the logos of Sanofi and Maze Therapeutics, separated by a
Sanofi and Maze Deal for MZE001 Terminated

Sanofi's agreement with Maze for MZE001 was scrapped due to an FTC complaint.

Source